Stock AnalizStevanato Group S.p.A. STVN
Medical/Dental Instruments · IPO 2021 · data as of November 13, 2026
Stevanato Group S.p.A. (STVN) is a healthcare company listed in the US with a market value of about $4.3B. In the twelve months to September 30, 2026 it had revenue of $1.4B and net income of $155M, a net margin of 11.2%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (0/5).
Key numbers: a P/E of 27.9, 5-year revenue growth of 11% a year, a 5-year average ROIC of 10%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 67% below the current price.
Score: 1.8 / 5
Checks passed
- Revenue growth above 10% last year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Liabilities below 60% of assets
- Pays a dividend
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.4B | $1.1B | $1.2B | $1.0B | $956M | $812M | $603M |
| Net income | $155M | $164M | $122M | $161M | $152M | $152M | $96M | $44M |
| Free cash flow | -$9M | $26M | -$153M | -$362M | -$140M | $29M | $81M | -$29M |
| EPS (diluted) | $0.57 | $0.60 | $0.45 | $0.59 | $0.56 | $0.56 | $0.35 | $0.16 |
| Net margin | 11.2% | 11.8% | 10.7% | 13.4% | 14.5% | 15.9% | 11.9% | 7.3% |
| ROIC | — | 7.6% | 6.5% | 10.2% | 12.3% | 12.4% | 13.0% | 16.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is Stevanato Group S.p.A.’s P/E ratio?
About 27.9, based on the last twelve months of diluted earnings per share (forward P/E about 21.8).
Is Stevanato Group S.p.A. stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 67% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Stevanato Group S.p.A. pay a dividend?
Yes. The dividend yield is about 0.39%, and it has paid dividends for 7 years in our data.
Is Stevanato Group S.p.A. a good stock to buy?
We do not give buy or sell advice. Stevanato Group S.p.A. scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.